SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp, high-volume selloff amid broader biotech weakness and options-expiration trading is driving discussion, with traders debating whether market positioning or concern about SELLASs extended quiet period is behind the decline. Bulls are focused on the pending REGAL Phase 3 event update and data, while bears question the trials prospects and the companys transparency.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a sharp neocloud and AI-infrastructure selloff as worries about CoreWeaves debt and rising financing costs weigh on the sector, alongside broader weakness in growth stocks. Traders debate whether NBIS is being unfairly lumped in with more leveraged peers, with bulls pointing to its stronger balance sheet and buying the dip while bears warn of further downside.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategys sharp selloff is centered on fears that proposed MSCI rules could lead to its exclusion from indexes and trigger fund selling; exclusion is not confirmed, and the company has challenged the proposal. Traders are split between expecting more downside from potential outflows and arguing the risk is priced in, while Bitcoin weakness adds pressure to the stock.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

RARI is drawing attention amid heavy speculation that its low market capitalization, limited circulating supply, and thin liquidity could magnify a return of trading volume. Bullish posts frame it as an accumulation or squeeze setup, while skeptics point to its sharp spike and subsequent fade and question the projects prospects as NFT interest has weakened.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Lingering concerns about weak revenue guidance, slowing ad-spend growth and competition continue to weigh on Trade Desk amid its prolonged decline. Traders are split between criticizing management and expecting further selling, and viewing the depressed share price and high short interest as potential grounds for a rebound; no fresh catalyst is clearly established.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is under pressure alongside a broader crypto selloff, with traders citing Bitcoin weakness and market uncertainty; reactions range from dip-buying to fears of further declines. The debate is sharpened by Ripple and institutional announcements that have not lifted the token, as some traders question whether RLUSD adoption and escrow releases benefit XRP holders directly.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBMs October 21 third-quarter report is the dominant focus, with bulls hoping software growth and delayed deals support results while skeptics question whether AI spending is translating into revenue and worry about slower software momentum. Quantum progress adds optimism for some traders, but sentiment is divided amid frustration with the stocks choppy performance.

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Curaleaf is under pressure as traders debate whether the selloff reflects uncertainty over its contested Aurora takeover bid or legal delays in federal cannabis rescheduling, including a request to reopen the hearing record. The community is split between criticism of the acquisition strategy and concern about rescheduling delays, while some argue the legal process is still moving forward.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC is drawing attention after a sharp cut to its third-quarter outlook, tied to weak demand, excess distributor inventory and price cuts as it resets its U.S. pricing model. Many traders fear the hit will worsen debt and bankruptcy risks, while some view the inventory cleanup as a painful step toward a turnaround.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick is drawing attention amid weakness in gold and repeated Elliott Wave analysis warning that its correction could extend; some traders link golds pullback to hotter inflation and increased Fed rate-hike expectations. The discussion is split between caution about further downside and bullish miners who view the pullback as an opportunity, citing longer-term demand for gold and hard assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Asked by reporters who was responsible for pausing access to Starlink for the Ukrainian military, President Donald Trump denied that either he or Musk was behind the move, according to a CNBC report.</li><li>SpaceX CEO Elon Musk had previously sought to distance himself from direct responsibility, saying that Starshield systems are owned and controlled by the U.S. government.</li><li>Ukrainian President Volodymyr Zelenskyy said on Friday that Starlink was not completely shut down in Ukraine but that its speed had been reduced.</li></ul><p>President Donald Trump on Friday denied that either the White House or Space Exploration Technologies Corp. (SPCX) CEO Elon Musk ordered restrictions on Starlink satellite internet services used by Ukraine’s armed forces.</p><p>The comments come after Ukrainian officials said the restrictions disrupted military operations and the country’s ability to intercept Russian attacks. Musk, meanwhile, had previously pointed responsibility toward the U.S. government, while conflicting reports have emerged over who ordered the slowdown.</p><p><a href="https://stocktwits.com/symbol/SPCX">SpaceX shares</a> fell nearly 2% during the regular trading session on Friday, and declined 0.4% further in the after-hours trade.</p><h2 class="st-heading-2">Trump Denies Ordering Starlink Restrictions</h2><p>Asked by reporters in Washington who was responsible for pausing access to Starlink for the Ukrainian military, Trump denied that either he or Musk was behind the move, according to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2026/10/16/trump-denies-musk-claim-he-ordered-starlink-restrictions-in-ukraine.html">report</a> by CNBC.</p><p>“Well, I don’t know if it was anybody because it wasn’t me, and I don’t think it was Elon,” Trump said. “And from what I understand, it’s the same as it’s always been.”</p><p>The denial follows reports pointing in different directions. Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/europe/order-limit-starshield-ukraine-came-inside-white-house-sources-say-2026-10-15/">reported</a> Thursday, citing two U.S. officials, that the call to restrict Starlink in Ukraine came from the White House, although the report did not identify who made the order.</p><p>The Telegraph, meanwhile,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.telegraph.co.uk/world-news/2026/10/16/musk-approached-trump-slow-down-starlink-help-ukraine/">reported</a> Friday that Musk had “approached” Trump with the idea of slowing down Starlink in Ukraine and that they both played a role in imposing the restrictions.</p><p>Musk had previously sought to distance himself from direct responsibility, writing&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/2110445577184133456">on</a> X that Starshield systems are owned and controlled by the U.S. government.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Musk_post_b0b5987cf6.jpg" alt="Elon Musk's post on X" width="590" height="355"><figcaption>Elon Musk's post on X | @elonmusk/X</figcaption></figure><p>The conflicting accounts come amid heightened tensions between Trump and Ukrainian President Volodymyr Zelenskyy over Ukraine’s attacks on Russian oil infrastructure.</p><h2 class="st-heading-2">Zelenskyy Says Starlink Was Slowed, Not Shut Off</h2><p>Zelenskyy said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/ZelenskyyUa/status/2111128466598854924">post</a> on X on Friday that Starlink was not completely shut down in Ukraine but that its speed had been reduced, with the restrictions having significant consequences for Ukrainian military operations.</p><p>According to Zelenskyy, the slowdown affected Ukraine’s ability to use Starlink-connected systems to intercept Russian drones attacking civilians. He said Ukrainian forces also rely on the service for mid-range strikes against Russian military targets in occupied Ukrainian territory.</p><p>“We couldn’t use a tool that helps protect people. That’s very painful and frustrating,” he added.</p><p>Zelenskyy also said the restrictions affected frontline logistics, including drones used to deliver food and water to Ukrainian soldiers. He said the service had begun to recover but had not yet returned completely to its previous performance.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Zelenskyy_post_f869aca6c3.jpg" alt=" Volodymyr Zelenskyy's post on X" width="585" height="619"><figcaption>&nbsp;Volodymyr Zelenskyy's post on X | @ZelenskyyUa/X</figcaption></figure><h2 class="st-heading-2">What Retail Investors Think Of SPCX Stock</h2><p>Retail sentiment on Stocktwits around SpaceX trended in the ‘bearish’ territory at the time of writing.</p><p><a href="https://stocktwits.com/symbol/SPCX">SPCX stock</a> is down 3% year-to-date. The S&amp;P 500 ETF (SPY) is up 16% over the past 12 months, while the Vanguard Morningstar Total Stock Market ETF (VTI) is up 15%.</p><p>Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-waives-russia-energy-tariffs-week-after-diesel-deal/cZxj6rdRBtJ"><strong>Trump Waives Russia Energy Tariffs, Sanctions A Week After Diesel Deal As Crude Oil Prices Soar To A 5-Month High</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Tesla and SpaceX CEO Elon Musk (L) receives the National Medal of Science from U.S. President Donald Trump during the Golden Age of American Innovation Summit at the Institute of Peace on October 08, 2026 in Washington, DC. (Photo by Win McNamee/Getty Images)

Trump Denies SpaceX’s Starlink Was Slowed Down Over Ukraine By Either White House Or Elon Musk: Report

The comments follow Ukrainian officials' remarks that the restrictions disrupted military operations and the country’s ability to intercept Russian attacks.

Equity

SpaceX

Vanguard Total Stock Market ETF

<ul class="summary-bullets"><li>The Graham Act, signed into law on Sept. 18, authorized sanctions, restrictions and duties targeting Russia and certain foreign persons and countries.</li><li>The law also allows the president to waive those measures if he certifies to Congress that doing so is in the national interest of the U.S.</li><li>Trump’s Oct. 16 executive order invokes that authority, stating that he has submitted the required certification and report to Congress.</li></ul><p>President Donald Trump has waived the application of new Russia-related sanctions and tariffs authorized under the recently enacted Lindsey O. Graham Sanctioning Russia and Iran Act.</p><p>The waiver, issued Friday, comes less than a month after Trump signed the Graham Act into law and about a week after the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-putin-deal-russia-diesel-prices/cZxTSILRBno">administration’s diesel deal</a> with Russia.</p><h2 class="st-heading-2">Trump Waives New Russia Tariffs</h2><p>The Graham Act, signed into law on Sept. 18, authorized sanctions, restrictions and duties targeting Russia and certain foreign persons and countries. The law also allows the president to waive those measures if he certifies to Congress that doing so is in the national interest of the U.S.</p><p>Trump’s Oct. 16 executive order invokes that authority, stating that he has submitted the required certification and report to Congress. The president waived the application of duties provided under key sections of the Graham Act, as well as several sanctions and restrictions targeting foreign persons.</p><p>However, the order leaves a framework in place for potentially steep tariffs on Russian goods and countries that continue to buy Russian energy or facilitate sanctions evasion.</p><p>The waiver will remain in effect until Trump or the Secretary of State, in consultation with other senior officials, determines that further action is appropriate.</p><p>Existing Russia-related sanctions imposed under earlier executive orders have been kept in place.</p><h2 class="st-heading-2">Trump Sets Up Sweeping Russia Tariff Structure</h2><p>Trump’s executive order also laid out a sweeping tariff structure that could be activated against Russia and countries involved in Russian energy trade.</p><p>The order calls for a 500% ad valorem duty on goods from Russia, subject to exceptions in the Graham Act and the waivers issued by Trump.</p><p>It also provides for an additional 100% tariff on goods from the five largest importers of Russian crude oil and natural gas if those countries knowingly make new purchases of Russian-origin crude or natural gas on or after Oct. 18.</p><p>The order directs the U.S. Trade Representative, working with the State, Treasury and Energy departments, to monitor Russian oil and gas purchases and sanctions evasion and regularly report developments to Trump.</p><h2 class="st-heading-2">Crude Oil Prices Hit Five-Month High</h2><p>Crude oil prices rose last week, with the U.S. West Texas Intermediate (WTI) futures expiring in November rising 10.88% to $101.84 a barrel after a 0.81% gain the week before. Brent crude futures expiring in December rose 4.91% this week, hovering around $109.69 a barrel after a 2.42% increase the week before.</p><p>The United States Oil Fund ETF (USO) rose about 3% on Friday, while the ProShares Ultra Bloomberg Crude Oil ETF (UCO) gained more than 4%.</p><p>During the after-hours session on Friday, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, fell 0.26%; the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) edged lower by 0.27%; and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) declined 0.21%. Retail sentiment on Stocktwits toward the S&amp;P 500 ETF was in the ‘bearish’ territory at the time of writing.</p><p>Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rtx-counter-drone-orders-aerovironment-palantir-defense-ai/cZxjx4bRBtI"><strong>Stocktwits Defense Watch: RTX Continues Deal Momentum, Ondas-Palantir Launch AI Firm As AeroVironment Strike Four International Deals</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

U.S. President Donald Trump speaks to the media on the South Lawn of the White House on September 26, 2026 in Washington, DC

Trump Waives Russia Energy Tariffs, Sanctions A Week After Diesel Deal As Crude Oil Prices Soar To A 5-Month High

The waiver, issued Friday, comes less than a month after Trump signed the Graham Act into law and about a week after the administration’s diesel deal with Russia.

ProShares Ultra Bloomberg Crude Oil

United States Oil Fund

<ul class="summary-bullets"><li>RTX received $729 million in counter-drone orders from the U.S., Qatar and Jordan.</li><li>AeroVironment expanded its international drone partnerships in Australia, Taiwan, Spain and Israel</li><li><a class="mention" data-mention="$ONDS" data-symbol-id="ONDS" href="https://stocktwits.com/symbol/ONDS" target="_blank">Ondas</a> and Palantir to launch an AI defense firm called Regna AI.</li></ul><p>Even as bank earnings and a tech selloff dominated market headlines this week, defense stocks were in the spotlight as demand for missile defense, counter-drone systems and advanced defense technologies remained an important theme amid geopolitical uncertainty in the Middle East.</p><p>After last week’s multibillion-dollar missile agreements involving Boeing and RTX, this week’s headlines focused on counter-drone systems, weapons production, military technology and AI.</p><p><img src="https://news.stocktwits-cdn.com/XF_1_RI_defense_deals_this_week_8bae0ba347.png" alt="XF1RI-defense-deals-this-week-.png"></p><h2 class="st-heading-2">Orders Galore For RTX’s Raytheon</h2><p>Raytheon, RTX’s unit, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.rtx.com/news/news-center/2026/10/13/rtxs-raytheon-awarded-729-million-in-counter-drone-contracts-for-u-s-qatar-a">announced</a> $729 million in contracts to supply components of its LIDS counter-drone system to the U.S. Army, Qatar and Jordan. The system combines KuRFS radar, which detects and tracks incoming drones, with Coyote interceptors designed to destroy individual drones and swarms.</p><p>The agreements mark the first international sales of both KuRFS and Coyote. RTX said it is increasing Coyote production to meet growing demand.</p><p>Separately, Raytheon won a contract from the Office of Naval Research (ONR) to develop advanced target‑detection capabilities for naval radar systems.&nbsp;On Thursday, Raytheon was <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.rtx.com/news/news-center/2026/10/15/rtxs-raytheon-selected-to-modernize-u-s-space-force-global-early-warning-radars">selected</a> to modernize U.S. Space Force radar sites to improve early warnings of missile launches, identify object types, and track activities in space.</p><h2 class="st-heading-2">L3Harris, HII Land New Military Orders</h2><p>L3Harris Technologies (LHX) <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.l3harris.com/newsroom/press-release/2026/10/l3harris-awarded-solid-rocket-motor-contract-record-production">received</a> a $250 million follow-on contract from Lockheed Martin (LMT) to manufacture propulsion systems for Guided Multiple Launch Rocket System rockets.</p><p>The company also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.l3harris.com/newsroom/press-release/2026/10/l3harris-provide-night-vision-systems-us-army">won</a> a $55 million U.S. Army contract to supply NOVA binocular night-vision goggles.</p><p>Meanwhile, shipbuilder HII<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.hii.com/news/hii-is-awarded-contract-to-support-aukus-engineering-and-design-work">&nbsp;secured</a> a $56 million U.S. Navy contract for engineering and design support under the AUKUS submarine partnership.</p><h2 class="st-heading-2">AeroVironment Expands International Drone Partnerships</h2><p>AeroVironment (AVAV) <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investor.avinc.com/news-events/press-releases">announced</a> four international partnerships this week, covering drone manufacturing, integration and communications technology.</p><p>The company signed an agreement with Australia’s NIOA to explore production of one-way attack drones. It also partnered with Taiwan’s Thunder Tiger on potential drone co-production and integration.</p><p>AeroVironment also signed agreements with Spain’s Alpha Unmanned Systems for maintenance, training and technical support for AVAV’s JUMP 20 surveillance drones and with Israel’s Elsight, which will provide communications technology for the Mayhem 10 drone system.</p><h2 class="st-heading-2">Ondas, Palantir Push Into Defense AI</h2><p>Ondas (ONDS) <a href="https://stocktwits.com/news-articles/markets/equity/ondas-palantir-partner-to-launch-new-ai-company-for-defense-missions-regna-ai/cZxIWo3RB8a">announced</a> a partnership with Palantir Technologies (PLTR) to launch an AI company for defense customers. Regna AI will develop specialized AI models for military missions involving drones, surveillance balloons, ground vehicles and unmanned vessels.</p><p>Regna AI will focus on sovereign AI, enabling governments to control their models, sensitive information, and computing infrastructure.</p><h2 class="st-heading-2">How Did HII, ONDS, LHX, AVAV And RTX Fare This Week?</h2><p>Stocks in this cohort have delivered mixed performance so far this week, with HII gaining 1.2%, L3Harris rising 0.94% and RTX edging up 0.16%, while AeroVironment fell 6.3% and Ondas declined 10%.</p><p><img src="https://news.stocktwits-cdn.com/Defense_stocks_YTD_f6ec89020b.png" alt="Defense stocks YTD.png"></p><p>On a year-to-date basis, RTX was the only gainer, up about 1.7%, while L3Harris declined 19.1%, HII fell 22.2%, Ondas plunged 37%, and AeroVironment crashed more than 50%.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

AeroVironment exhibited during the Defense Expo Korea 2022, held at KINTEX (Korea International Exhibition and Convention Center) on September 21, 2022 in Goyang city, Gyeonggi, South Korea. 

Stocktwits Defense Watch: RTX Continues Deal Momentum, Ondas-Palantir Launch AI Firm As AeroVironment Strike Four International Deals

U.S.-listed defense companies continued to rack up fresh orders and partnerships, with counter-drone technology and military AI taking center stage.

RTX, AeroVironment And Ondas-Palantir Push Deeper Into Drone Defense And AI This Week

U.S.-listed defense companies continued to rack up fresh orders and partnerships, with counter-drone technology and military AI taking center stage.


AeroVironment Inc.

Huntington Ingalls Industries Inc

L3Harris Technologies Inc

Ondas Inc

Raytheon Technologies Corporation

<ul class="summary-bullets"><li>Tesla CEO Elon Musk floated the possibility of launching an Amazon competitor after the e-commerce company blocked Grok Bot from making purchases on its platform.</li><li>Meanwhile, Nvidia CEO Jensen Huang said Nvidia and SpaceX are exploring space-based data centers, with their engineering teams developing server architecture for use both in orbit and on Earth.</li><li>Huang also called for the U.S. and China to cooperate on AI safety.</li></ul><p>The CEOs of Magnificent Seven companies offered more insights into their AI strategies this week. Tesla (TSLA) and SpaceX (SPCX) CEO Elon Musk was at the helm of the Roadster reveal and promised to reimburse Grok Bot purchase errors, while Nvidia (NVDA) CEO Jensen Huang made comments on AI safety and Microsoft (MSFT) CEO Satya Nadella issued a warning about security risks from AI models.</p><p>Meta (META) CEO Mark Zuckerberg pushed a new consumer-focused AI strategy, and at Apple (AAPL), incoming CEO John Ternus defended the company’s approach to product design and left the door open to using Chinese chips.&nbsp;</p><p>Meanwhile, tech giant Alphabet’s (GOOG, GOOGL) CEO Sundar Pichai spent the week promoting Google’s latest AI model, while Amazon (AMZN) CEO Andy Jassy was largely missing from commentary.</p><p>Here’s the complete rundown:</p><h2 class="st-heading-2">Elon Musk: Tesla, SpaceX And Nvidia</h2><blockquote><p><strong>“Turns out the future does have flying cars.”</strong></p><p>– Elon Musk, CEO, SpaceX/Tesla, after the Roadster reveal</p></blockquote><p>Musk’s long-awaited Roadster demonstration was broadcast as a joint Tesla-SpaceX event. “Well, it worked,” he said, after the car’s most dramatic moment came when it used thrusters to land after an inverted jump.</p><p>The demonstration drew investor attention and focus towards the engineering that went into its creation, but its commercial viability remains less clear. Investor Gene Munster&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/munster_gene/status/2110906621501063590">called</a> it an “engineering flex” with no commercial value, while suggesting the event might be another hint at a potential SpaceX and Tesla merger.</p><p>Tesla says Roadster production will begin in 2028. However, Musk has acknowledged that the car will not materially move the company’s revenue. Tesla’s earnings report, slated to land next week, will provide a more direct look at the business behind the spectacle.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_16_051122_70cbf89ec3.png" alt="Screenshot 2026-10-16 051122.png" width="1268" height="684"><figcaption>TSLA stock retail sentiment on October 16 | Source: Stocktwits</figcaption></figure><p>On Stocktwits, retail sentiment behind&nbsp;<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> slipped to ‘bearish’ from ‘neutral’ territory over the past week. Platform data showed chatter increasing by nearly 150% in the last seven days..</p><blockquote><p><strong>“SpaceX will make you whole.”</strong></p><p>– Elon Musk, CEO, SpaceX/Tesla, on Grok Bot purchase errors</p></blockquote><p>Musk continued to stay active on X. Responding to a user whose flight Grok Bot had booked using an image of a payment card, he&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/2110610960474079445">said</a> SpaceX would reimburse users if the bot made an incorrect purchase or exposed their card details.</p><p>The pledge came after SpaceX Super Intelligence&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/SpaceXSI/status/2109783335296008414">introduced</a> a single subscription combining Grok, Grok Bot, Cursor and X Premium earlier in the week.</p><blockquote><p><strong>“Maybe we should start a competitor to Amazon.”</strong></p><p>– Elon Musk, CEO, SpaceX/Tesla, on Grok Bot purchase errors</p></blockquote><p>Musk also floated the idea of starting a competitor to Amazon after e-commerce giant blocked Grok Bot from making purchases on its platform. This marks a rare instance of a Magnificent Seven CEO publicly floating a rival to its peer so publicly.&nbsp;</p><blockquote><p><strong>“Old friends are the best friends. Jensen rocks.”</strong></p><p>– Elon Musk, CEO, SpaceX/Tesla, on Nvidia CEO comments during interview</p></blockquote><p>Musk’s praise for Huang allowed the Nvidia CEO’s remarks on a BG2 podcast, where he said that Nvidia now counts SpaceX alongside its cloud provider customers, and that the two companies’ engineers are designing a new kind of server for space and Earth.&nbsp;</p><p>Musk said Star Mind, which SpaceX is co-engineering with Nvidia, is “far better than almost anyone expects” and will reach volume production next year. Working with Nvidia’s engineers, he added, “is pure joy!”</p><h2 class="st-heading-2">Jensen Huang: Nvidia, Musk, AI Safety And China</h2><blockquote><p><strong>“Nobody knows more about energy than he does.”</strong></p><p>– Jensen Huang, CEO, Nvidia, on Elon Musk, on BG2 Pod podcast</p></blockquote><p>On the B2G podcast, Huang said Nvidia used to count Musk’s companies as enterprise customers and now counts them alongside its cloud service providers. He added that the demand for Grok Bot is “really skyrocketing.”&nbsp;</p><p>Huang also noted that Musk loves the intersection of computing and physical build-outs. He then said the two companies will explore “putting data centers out in space” together, with their engineering teams working closely on a new type of server architecture that “might be super good” both in orbit and on Earth.</p><blockquote><p><strong>&nbsp;“We absolutely should work with each other so that we advance the technology safely.”</strong></p><p>– Jensen Huang, CEO, Nvidia, to press in London&nbsp;</p></blockquote><p>Huang travelled to Europe this week, and told the press that the U.S. and China need to work together and maintain dialogue to ensure the “<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-jensen-huang-says-us-absolutely-must-work-with-china-on-potentially-dangerous-ai/cZxWvlSRBAH">potentially dangerous</a>” technology develops safely.</p><p>According to him, the AI trade remains strong. Speaking at an event in Stockholm, Huang&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-s-huang-signals-core-weave-financials-improving-with-decreasing-cost-of-capital/cZxhTzPRBr9">expressed</a> confidence in CoreWeave's operational trajectory despite intense scrutiny from credit markets and equity investors. "CoreWeave's strength is improving every day," Huang said. "I'm optimistic. Their cost of capital is actually decreasing."</p><p>On Stocktwits, retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/NVDA">NVDA stock</a> continued to trend in ‘bearish’ territory over the past week. Platform data showed chatter increasing by only 14% in the last seven days.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_16_050841_9e506869e3.png" alt="Screenshot 2026-10-16 050841.png" width="1266" height="690"><figcaption>NVDA stock retail sentiment on October 16 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Meta’s Zuckerberg Pitches A More Personal AI Future&nbsp;</h2><blockquote><p><strong>“Personal superintelligence for everyone.”</strong></p><p>– Mark Zuckerberg, CEO, META, on Threads announcing Muse Wonder</p></blockquote><p>Zuckerberg used the launch of Muse Wonder to focus on his consumer-focused vision for AI. Meta said the new models were trained in its Prometheus gigawatt data center and underpin its model API and Muse Code agent.</p><p>The company’s pitch also draws a distinction between its approach and competitors’ priorities. Zuckerberg said Meta was “much more focused on personal empowerment” than knowledge-work automation.&nbsp;</p><p>On Stocktwits, retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/META">META stock</a> continued to trend in ‘bearish’ territory over the past week. Platform data showed chatter dropping by 7% in the last seven days.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_16_051113_e17e8ee3d7.png" alt="Screenshot 2026-10-16 051113.png" width="1260" height="690"><figcaption>META stock retail sentiment on October 16 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Microsoft’s Nadella Says AI Models Need To Be Contained</h2><blockquote><p><strong>“We must assume a model is compromised and contain it from the start.”</strong></p><p>– Satya Nadella, CEO, Microsoft in a post titled “Models as Insider Risks in the Super Intelligence Era” on X</p></blockquote><p>Nadella’s post continued to shape the week’s discussion about AI security. He argued that companies should treat AI models as potential insider risks, rather than assume they will behave safely once deployed.</p><p>His suggestion was to “separate the supply of intelligence from the authority over it.” He also said an authorized person should always be able to “pause or shut down a model mid-task.”</p><p>On Stocktwits, retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/MSFT">MSFT stock</a> shifted to ‘bearish’ from ‘neutral’ territory over the past week. Platform data showed chatter dropping by 43% in the last seven days.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_16_051122_70cbf89ec3.png" alt="Screenshot 2026-10-16 051122.png" width="1268" height="684"><figcaption>MSFT stock retail sentiment on October 16 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Apple’s Ternus Defends Product Choices And Keeps Options Open</h2><blockquote><p><strong>“Kind of cheap and crappy.”</strong></p><p>John Ternus, CEO, Apple to TIME, discussing earlier foldable phones</p></blockquote><p>Ternus, in an interview with TIME, said Apple's approach to product design, included waiting before entering categories where competing products were already available.</p><p>According to him, Apple’s approach is based around prioritization rather than simply criticizing rivals. “You can’t do everything,” he said, adding that the company concentrates on what matters most. Apple’s iPhone Duo is slated to launch next week.&nbsp;</p><blockquote><p><strong>“All options should be on the table.”</strong></p><p>John Ternus, CEO, Apple to CNBC, on reports that Apple tested Chinese chips</p></blockquote><p>Ternus this week also addressed reports that Apple had tested chips from China, saying that “all options should be on the table.” The comment came during a wider discussion of the iPhone Duo, memory shortages and AI.</p><p>On Stocktwits, retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/AAPL">AAPL stock</a> saw the largest shift, dropping to ‘extremely bearish’ from ‘neutral’ territory over the past week. However, platform data showed chatter rose dropping by 13% in the last seven days.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_16_051625_c9a81cd2e1.png" alt="Screenshot 2026-10-16 051625.png" width="1268" height="682"><figcaption>AAPL stock retail sentiment on October 16 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Alphabet’s Pichai Pushes Gemini 4 Argon To More Users&nbsp;</h2><p>Pichai this week announced the expansion of Gemini 4 Argon beyond cybersecurity specialists to enterprise customers and Pro and Ultra subscribers. Introductory pricing was set at $2 and $10 per million tokens through November 30.</p><p>The rollout comes amid efforts by Google to strengthen its position in the AI market following delays, the abandonment of Gemini 3.5 Pro.</p><p>Google Quantum AI achieved a milestone this week by demonstrating magic state cultivation on its Willow quantum processor, reducing quantum computing errors by 40 times.</p><p>Pichai also reacted to Musk’s Roadster demonstration. “The FSD version of this will be something,” he wrote on X. Alphabet owns Waymo, which operates in autonomous driving as a competitor to Tesla.</p><p>Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/GOOGL">GOOGL stock</a> on Stocktwits flipped to ‘bearish’ from the ‘bullish’ zone over the past week. Chatter also dropped with platform data showing an over 37% decrease in message volumes.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_16_041015_3bf773296f.png" alt="Screenshot 2026-10-16 041015.png" width="1264" height="690"><figcaption>GOOGL stock retail sentiment on October 16 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Amazon: Few New Jassy Comments, But Agent Strategy Stands Out</h2><p>There were no new remarks from Jassy this week. However, a spokesperson for the company did address the controversy with Musk’s Grok Bot. They said third-party shopping apps should “operate openly and respect service provider decisions.”</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_16_051631_0bbf7ca03a.png" alt="Screenshot 2026-10-16 051631.png" width="1264" height="708"><figcaption>AMZN stock retail sentiment on October 16 | Source: Stocktwits</figcaption></figure><p>Like GOOGL shares,&nbsp;<a href="https://stocktwits.com/symbol/AMZN">AMZN stock</a> also saw retail sentiment on Stocktwits flip to ‘bearish’ from ‘bullish’ territory over the past week, alongside a 17% increase in chatter.</p><p><strong>Read also:&nbsp;</strong><a href="https://stocktwits.com/news-articles/markets/equity/crwv-stock-4-day-slide-coreweave-debt-test-analysts-split-selloff/cZxWuGmRBAA"><strong>CRWV Stock On Track For 4-Day Slide Amid CoreWeave’s Debt Test: Analysts Split On Whether Selloff ‘Grossly Overexaggerated’</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Tesla and SpaceX CEO Elon Musk reacts after being awarded the National Medal of Science at the Institute of Peace on October 08, 2026. AI leaders including Elon Musk, Sergey Brin, Jensen Huang, Lisa Su, Michael Dell, and Satya Nadella were also present. (Photo by Win McNamee/Getty Images)

Elon Musk’s Roadster, Nvidia’s Space AI Push, Nadella’s Security Warning: Mag 7 Voices This Week

The CEOs of Magnificent Seven companies offered more insights into their AI strategies this week. Tesla (TSLA) and SpaceX (SPCX) CEO Elon Musk was at the helm of the Roadster reveal and promised to reimburse Grok Bot purchase errors, while Nvidia (NVDA) C

Elon Musk’s Roadster, Nvidia’s Space AI Push, Nadella’s Security Warning: What Mag 7 CEOs Said This Week

Elon Musk said Tesla’s long-awaited Roadster will enter production in 2028, though he has acknowledged that the car is unlikely to materially affect the company’s revenue.


Apple Inc

Amazon.com Inc

Alphabet Inc Class A

Roundhill Magnificent Seven ETF

Microsoft Corp

<ul class="summary-bullets"><li>The U.S. dollar index dropped 0.2% on Friday, completing its sharpest weekly decline since early September as traders lowered probabilities of an October rate hike to 20%.</li><li>The U.S. Treasury Department released primary dealer survey questions that omitted direct references to cutting 20-year bond issuances or scaling back long-end debt auctions.&nbsp;</li><li>The yield curve flattened further this week, with 10-year yields falling about 16 basis points over the previous week.</li></ul><p>U.S. government bond prices retreated, and the dollar suffered its sharpest weekly decline in over a month during the week ending&nbsp;Oct. 16, as fixed-income investors digested ambiguous signals from Kevin Warsh on the future course of interest rates.&nbsp;</p><p>Federal Reserve Chairman Kevin Warsh declined to provide forward guidance on interest rate trajectory during remarks at the International Monetary Fund meetings in Bangkok. Warsh's silence led traders to pare back probabilities of an October rate hike to 20%.&nbsp;</p><p>"Warsh offered no guidance, which while it should be expected of him at this point, the market is taking it as a signal that the October Fed meeting is likely a no go," Noah Buffam at CIVB Capital Markets told Bloomberg in an interview.&nbsp;</p><p>Moreover, adding to the dissent among fixed income traders, the U.S. Department of the Treasury did not provide information or explicit proposals to reduce long-duration debt issuances or eliminate 20-year auctions, which primary dealers were expecting.</p><p>The 30-year U.S. Treasury yield slipped 17 basis points from the previous week to 5.43%, while the 10-year yield eased slightly to 5.08% and 2-year yields settled at 4.72% for the week ending Oct. 16.</p><p>The spread between the U.S.&nbsp;10-year&nbsp;yield and the U.S.&nbsp;2-year&nbsp;yield ticked lower to 0.37% in the week, from 0.44% a week ago.</p><p>The iShares 20+ Year Treasury ETF (<a class="mention" data-mention="$TLT" data-symbol-id="TLT" href="https://stocktwits.com/symbol/TLT" target="_blank">TLT</a>) ended the week 2.7% higher, while the shorter-duration iShares 1-3 year ETF (SHY) added about 0.2%. The slight recovery in the shorter-duration bond ETF may reflect easing short-term inflation pressure; however, markets still factor in one more rate hike in December.&nbsp;&nbsp;</p><p>Retail sentiment on TLT and SHY was ‘bullish,’ with ‘high’ message volumes.</p><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Asset / Benchmark&nbsp;</td><td>Weekly Close&nbsp;</td><td>Weekly Change&nbsp;</td></tr><tr><td>U.S. Dollar Index&nbsp;</td><td>101.78&nbsp;</td><td>-0.3%&nbsp;</td></tr><tr><td>U.S. 2-Year Treasury Yield&nbsp;</td><td>4.72%&nbsp;</td><td>-7 bps&nbsp;</td></tr><tr><td>U.S. 10-Year Treasury Yield&nbsp;</td><td>5.08%</td><td>-16 bps&nbsp;</td></tr><tr><td>U.S. 30-Year Treasury Yield&nbsp;</td><td>5.42%</td><td>-17 bps&nbsp;</td></tr><tr><td>U.S. 10Y2Y Yield Spread&nbsp;</td><td>Flattening curve</td><td>-</td></tr></tbody></table></figure></div><h2 class="st-heading-2"><strong>Yield Curve &amp; Global Sovereign Markets&nbsp;</strong></h2><p>Yield curve flattening trends persisted as short-duration yields outpaced gains at the long end, keeping the gap between 2-year and 10-year Treasuries tightly compressed.</p><p><img src="https://news.stocktwits-cdn.com/koyfin_20261017_054625677_be83e32d82.png" alt="koyfin_20261017_054625677.png"></p><p>The bond rout expanded across international sovereign bond markets. European government bond yields rose alongside U.S. peers, with German Bunds, UK Gilts and French bonds all remaining elevated amid soaring inflation pressures.&nbsp;</p><h2 class="st-heading-2"><strong>Greenback &amp; Economic Data Roundup</strong></h2><p>The Dollar Spot Index slipped 0.2% on Friday, snapping a multi-week rally and registering its worst weekly performance since September 4. The dollar fell against all major developed market currencies, allowing the euro to break a five-week losing streak.&nbsp;</p><p>Hotter-than-expected September CPI data and solid retail sales initially supported rate-hike expectations earlier in the week, but investors questioned the durability of the artificial intelligence boom that has supported U.S. growth, putting pressure on the greenback.&nbsp;</p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

A trader works on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York on March 24, 2026. European and US stocks resumed sliding and oil prices jumped on Tuesday as traders turned cautious over the prospect of a negotiated agreement between the United States and Iran to end the Middle East war. (Photo by ANGELA WEISS / AFP via Getty Images)

Stocktwits Weekly Spread: What Shaped Treasury Yields And The Dollar This Week  

U.S. government bond prices retreated, and the dollar suffered its sharpest weekly decline in over a month during the week ending Oct. 16, as fixed-income investors digested ambiguous signals from Kevin Warsh on the future course of interest rates.

Stocktwits Weekly Spread: What Shaped Treasury Yields And The Dollar This Week

An accelerating rout in AI stocks sent the U.S. dollar to its worst weekly drop in a month while Treasuries resumed their slide for the week ending Oct. 16. 


Pimco Exchange Traded Fund - PIMCO Active Bond ETF

iShares U.S. Treasury Bond ETF

iShares 1-3 Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

<ul class="summary-bullets"><li>PayPal extended its rally on AI-driven shopping expansion, while Fiserv faced price target cuts over its revenue growth projections.</li><li>SoFi Technologies and Affirm Holdings (AFRM) continue to navigate interest rate headwinds, ending the week lower.</li><li>The Consumer Financial Protection Bureau (CFPB) launched a formal enforcement initiative targeting unlawful "debanking" practices by major financial institutions.&nbsp;</li></ul><p>Regulatory measures by the Consumer Financial Protection Bureau (CFPB) to tackle unlawful debanking practices by financial institutions, a range of analyst price target and outlook shifts, and tech market volatility affecting payment processors and retail brokerages were central themes during the week of October 12.</p><p>Fintechs with yield-bearing deposit products continued to tackle pressure from the Federal&nbsp;Reserve's recent interest rate hike along with increasing bets for another bump in rates at the end of the year. While elevated interest rates help net interest margins for deposit-heavy platforms,&nbsp;they temper&nbsp;consumer borrowing appetite, which has already taken a hit on account of soaring inflationary pressures.&nbsp;</p><h2 class="st-heading-2"><strong>Infrastructure Shifts Across Mastercard, PayPal, And Fiserv&nbsp;</strong></h2><p>Mastercard Incorporated (MA): Mastercard announced a strategic partnership on Oct. 12 with WEX to launch the Asia-Pacific region’s first unified fleet payments network, integrating fuel, maintenance, and tolling transactions into a single infrastructure.&nbsp;</p><p>PayPal Holdings Inc. (PYPL): PayPal shares extended a multi-day rally, ending its second consecutive week higher, after the company announced partnering with AI shopping agent provider Glance to embed instant AI-driven shopping checkout capabilities.</p><p>Fiserv Inc. (FISV): Cantor Fitzgerald, Barclays, and TD Cowen lowered their price targets amid an ongoing shareholder lawsuit that urged a federal court to deny Fiserv's motion on the back of revenue guidance resets. However, despite the price target cuts, <a class="mention" data-mention="$FISV" data-symbol-id="FISV" href="https://stocktwits.com/symbol/FISV" target="_blank">FISV stock</a> ended the week about 4% higher.</p><h2 class="st-heading-2"><strong>How Neobank SoFi Performed&nbsp;</strong></h2><p>SoFi Technologies Inc. (SOFI):&nbsp;SoFi shares dropped to a 52-week low of $13.86 amid investor concerns over revenue expansion outpacing bottom-line profitability gains.</p><p>While the platform posted Q2 net revenue of $1.22 billion and bumped its full-year top-line guidance to a range of $4.75 billion to $4.85 billion, full-year adjusted EPS projections held flat near $0.60 as elevated marketing spend and acquisition expenses squeezed profit margins.</p><p>Last week, Keefe Bruyette lowered its price target for SoFi to $15 from $16 and maintained an ‘Underperform’ rating. The firm expects rising interest rates and SoFi’s growing balance sheet to create more than $1 billion in pressure this quarter, forcing the company to issue more loans while reducing its available capital.&nbsp;</p><h2 class="st-heading-2"><strong>Analysts Bearish On Robinhood&nbsp;</strong></h2><p>Wells Fargo lowered Robinhood's price target to $120 from $125 and kept an Equal Weight rating on the shares earlier this week. Meanwhile, founder and CEO Vlad Tenev sold nearly $43 million in company stock this month, but Barron's reported he’s far from cashing out.&nbsp;</p><p>Tenev’s stock sale aligned with a broader surge in Bitcoin in early October, which propelled the digital asset above $86,000. However, this upward trajectory hit friction as digital currency markets encountered macroeconomic headwinds from surging crude prices and advancing Treasury yields.</p><p>Robinhood share price dropped over 9% this week to record its fourth consecutive weekly decline.&nbsp;</p><h2 class="st-heading-2"><strong>Federal Rules And Legal Updates&nbsp;</strong></h2><p>On Oct. 14, the Consumer Financial Protection Bureau announced a targeted initiative investigating major financial institutions for potential unlawful "debanking". The investigation evaluates whether arbitrary account closures violate the Equal Credit Opportunity Act (ECOA) or rules prohibiting unfair, deceptive, or abusive acts or practices (UDAAP).&nbsp;</p>

Digital Futuristic abstract background of Money currency in cyberspace. (Image Courtesy: Getty Images)

Stocktwits Fintech Pulse: US Fintech Weekly Briefing & Market Drivers 

Regulatory measures by the Consumer Financial Protection Bureau (CFPB) to tackle unlawful debanking practices by financial institutions, a range of analyst price target and outlook shifts, and tech market volatility affecting payment processors and retail

Stocktwits Fintech Pulse: US Fintech Weekly Briefing & Market Drivers

Payment infrastructure providers and retail brokerages face analyst guidance resets, and U.S. regulators target “debanking” this week. 

Fiserv, Inc.

Robinhood Markets Inc

Mastercard Inc

PayPal Holdings Inc

SoFi Technologies Inc

<ul class="summary-bullets"><li><a class="mention" data-mention="$TSLA" data-symbol-id="TSLA" href="https://stocktwits.com/symbol/TSLA" target="_blank">Tesla</a> showed the redesigned Roadster at a SpaceX site near Waco, claiming sub-1-second 0-60 mph, more than 230 mph top speed, and 2028 production, with reservations starting at $50,000.</li><li>Rivian said future vehicles will run third-party AI agents and received EPA approval for longer-range 2027 commercial vans with a 129 kWh pack.</li><li>GM’s Mary Barra defended the exit from Cruise robotaxis while staying on track for eyes-off driving by 2028.</li></ul><p>Electric vehicles outpaced consumer imagination this week after giant Tesla Inc (TSLA) finally unveiled its long-delayed next-generation Roadster on Thursday with SpaceX thrusters that let the car drive upside down, flip midair, and jump obstacles as high as the company’s own Semi truck, while rivals stuck to advancing software, commercial products, and markets.</p><h2 class="st-heading-2"><a href="https://stocktwits.com/symbol/TSLA">Tesla</a> Roadster Takes Flight</h2><p>Tesla on Thursday unveiled the redesigned Roadster at a SpaceX test site near Waco in Texas. The vehicle is developed with technology borrowed from SpaceX, and the display model showed a two-seater interior with a suction system that Musk assured will ease corner maneuvering in addition to helping the car hang upside down, and cold gas thrusters that allow it to flip in the air.</p><p>Vehicle engineering chief Lars Moravy said the car can accelerate from 0 to 60 mph in less than one second and reach a top speed of more than 230 mph, with range listed above 300 miles. Musk at the event also termed the car potentially “the only manually driven car Tesla makes,” though stunts at the event were performed autonomously. He also said that the vehicle might not be legal in all jurisdictions.</p><p>Production for the vehicle, which Musk has previously warned will not move the needle for Tesla financials in a big way, is slated to start in 2028. The company did not disclose a price point for the vehicle, but updated its reservation page to list three variants, including a base version one can reserve for $50,000, a Thrust model which can be reserved for $250,000, and a limited edition Rocket single-seat variant which is invite-only. Tesla said in its reservation agreement that it cannot confirm the purchase price of the vehicle just yet, and reservation holders will know the cost only once they have configured their vehicle order at a later date.</p><h2 class="st-heading-2"><a href="https://stocktwits.com/symbol/RIVN">Rivian</a> Pushes AI Agents And Longer-Range Vans</h2><p>Rivian CEO RJ Scaringe said at TechCrunch Disrupt this week that future Rivian vehicles will be able to run AI agents from outside companies such as Anthropic, building on the company’s own in-car assistant. He described an agentic framework that routes voice requests to local or cloud models depending on complexity. Timing was not given; the company instead pointed to its December AI &amp; Autonomy Day.</p><p>Separately, Rivian received EPA approval for 2027 model-year commercial vans with a larger 129 kWh LFP battery and optional dual-motor all-wheel drive. The larger pack raises the EDV 700's lab-tested range to 355 miles in front-wheel-drive and 322 miles with all-wheel drive, Electric Vehicles reported.</p><h2 class="st-heading-2"><a href="https://stocktwits.com/symbol/LCID">Lucid</a> Eyes New Market</h2><p>Lucid, meanwhile, announced plans to deliver its electric vehicles in France starting in the first quarter of 2027 as it tackles weak demand for its higher-end offerings. &nbsp;<br>The company intends to open its initial retail and service locations in France, working with local partner Emil Frey France, and aims to expand the network to more than 16 partner sites by the end of the year. Vehicles are on display this week at the Paris Motor Show, running October 12–18, marking Lucid’s first appearance at the event.</p><h2 class="st-heading-2"><a href="https://stocktwits.com/symbol/F">Ford</a>-Geely JV Clears</h2><p>Chinese regulators unconditionally approved a joint venture between Ford and Geely that lets Geely take a portion of Ford’s dormant Valencia plant in Spain for local production aimed at avoiding tariffs. The partners also plan a Blue Oval-badged SUV on Geely’s platform expected to be offered with more than one powertrain type, and production targeted for 2028.</p><h2 class="st-heading-2"><a href="https://stocktwits.com/symbol/GM">General Motors</a>’ Barra Defends Exit From Robotaxis</h2><p>General Motors CEO Mary Barra, speaking on CNBC’s Mad Money this week, reaffirmed that the company remains on track for eyes-off, hands-off driving in personal vehicles by 2028, starting with the electric Cadillac Escalade IQ. She defended the decision to exit the all-electric Cruise robotaxi business after spending more than $10 billion, saying GM is “not in the taxi business” or “the bus business” even while rivals attempt to scale autonomous vehicles.</p><p>GM exited Cruise in late 2024 and folded the unit into its driver-assistance efforts after one of its electric robotaxis was involved in an accident in San Francisco. “When we looked at the capital that we were going to need… It was a tough decision, but I think it was the right decision,” she said.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around TSLA and F stayed within the bearish territory over the past 24 hours, while sentiment around RIVN and GM stayed within the neutral territory. Sentiment around LCID was bullish at the time of writing.</p><p>TSLA has dropped 21% year-to-date. GM and F have clocked single-digit gains or losses in the period, while LCID slipped 70% and RIVN dropped 34%.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/stocktwits-biotech-dealmaker-gilead-astra-zeneca-and-roche-chase-pipeline-expansion-over-buyouts/cZxKjksRBtP">Stocktwits Biotech Dealmaker: Gilead, AstraZeneca And Roche Chase Pipeline Expansion Over Buyouts</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Yellow electric car charging at electric charging station. Source: Getty Images

Stocktwits Zero To Sixty — Tesla’s Roadster Flies With SpaceX Thrusters, Rivian Opens Cars To AI Agents, And Lucid Eyes France

Tesla’s long-delayed Roadster finally appears with SpaceX thrusters, as rivals push AI agents, longer-range commercial vans, and European production deals.

Ford Motor Co

General Motors Company

Lucid Group Inc

Rivian Automotive Inc

<ul class="summary-bullets"><li><a class="mention" data-mention="$GILD" data-symbol-id="GILD" href="https://stocktwits.com/symbol/GILD" target="_blank">Gilead Sciences</a> partnered with Vir Biotechnology on Wednesday to discover and develop three drugs aimed at solid tumors.</li><li>AstraZeneca signed an up-to-$1.5 billion AI collaboration with insitro for MASH and cardiomyopathies.&nbsp;</li><li>Roche licensed Rona’s drug candidate, and Zealand Pharma teamed with Generate on AI-designed proteins for differentiated obesity approaches.</li></ul><p>Large pharmaceutical companies including Gilead Sciences, Roche and AstraZeneca spent this week securing access to discovery technologies and experimental candidates that address clear biological gaps, instead of large-scale acquisitions of rival firms or approved products.</p><p>Obesity and cancer remained the clear focal points, with several of the week’s biggest partnerships aimed at differentiated weight-loss mechanisms or new solid-tumor approaches.</p><h2 class="st-heading-2">Gilead Partners With Vir For New Cancer Drug Candidates</h2><p>Gilead Sciences (GILD) partnered with Vir Biotechnology (VIR) on Wednesday to discover and develop three drugs aimed at solid tumors. Vir will handle early discovery, design, and optimization using its AI-enabled protein engineering tools and PRO-XTEN masking technology. Gilead receives exclusive rights to nominate candidates and will lead subsequent development, manufacturing, and commercialization.</p><p>Vir is eligible for $90 million upfront—$65 million in cash plus a $25 million equity investment at a premium—plus up to $45 million in near-term preclinical milestones and as much as $1.74 billion in later development, regulatory, and commercial payments, along with tiered royalties. The agreement marks Vir’s second major partnership around its masking platform this year after a previous deal with Astellas and adds to Gilead’s attempts to advance its cancer offerings besides its blockbuster drug Trodelvy.</p><h2 class="st-heading-2">AstraZeneca Taps Insitro’s AI Platform</h2><p>AstraZeneca (AZN) signed a worldwide exclusive research collaboration with privately held AI therapeutics company insitro focused on metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies. Insitro will apply its Virtual Human platform, which combines human and cellular data with AI, to identify causal disease biology and advance AstraZeneca-nominated targets through discovery to the development-candidate stage.</p><p>AstraZeneca will lead clinical development, regulatory work, and commercialization. Insitro will receive $40 million upfront and is eligible for up to approximately $1.46 billion in discovery, development, and commercial milestones, plus single-digit royalties on potential sales.</p><h2 class="st-heading-2">Roche, Zealand Pharma Add Differentiated Obesity Approaches</h2><p>Roche secured exclusive worldwide rights to Rona Therapeutics’ investigational drug candidate which targets a protein predominantly expressed in fat tissues. The drug candidate is designed to selectively reduce visceral and ectopic fat while preserving lean mass—an attractive complement to currently popular obesity drug classes like GLP-1. Rona is eligible for up to $100 million in upfront and near-term payments, up to $1.06 billion in additional milestones, and tiered royalties.</p><p>Separately, Zealand Pharma entered a collaboration with Generate Biomedicines (GENB) to design multispecific protein therapeutics for obesity and other metabolic diseases using Generate’s generative AI platform. Generate will lead research through lead-candidate selection for two initial programs, with an option for a third; Zealand will handle clinical development, regulatory submissions, and commercialization. Generate receives $30 million upfront, up to $35 million in early preclinical milestones, and nearly $1.2 billion in total potential milestones, plus royalties.</p><h2 class="st-heading-2">Pfizer, Galderma Make Platform And Commercial Moves</h2><p>Pfizer (PFE) partnered with privately-held Enodia Therapeutics on a research collaboration and license for compounds intended to block disease-driving proteins at the point of synthesis. The potential value exceeds $500 million, including an upfront payment, milestones, and royalties; Enodia will run discovery against multiple targets while Pfizer takes over later development and commercialization.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around SPDR S&amp;P Biotech ETF (XBI) fell from bullish to neutral territory over the past 24 hours, while message volume stayed at normal levels.</p><p><a href="https://stocktwits.com/symbol/XBI">XBI</a> has fallen 4% over the past week as part of a broader biotech pullback that began after its mid-August peak near $170, but it is up 22.5% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/novartis-discontinues-mid-stage-lupus-trial-in-latest-pipeline-setback/cZxKiBhRBtc">Novartis Discontinues Mid-Stage Lupus Trial In Latest Pipeline Setback</a></p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

Digital background depicting innovative technologies in medicine systems. Source: Getty Images

Stocktwits Biotech Dealmaker: Gilead, AstraZeneca And Roche Chase Pipeline Expansion Over Buyouts

Deals for AI discovery platforms and differentiated experimental candidates for obesity and solid tumors dominated the week.

AstraZeneca PLC

Generate Biomedicines Inc

Gilead Sciences, Inc.

Pfizer Inc

Roche Holdings AG ADR

Vir Biotechnology Inc

SPDR S&P Biotech ETF

<ul class="summary-bullets"><li>The S&amp;P 500 ended Friday 1.1% lower, the Nasdaq 100 fell 2.5%, and the Dow Jones Industrial Average slipped 0.3%.</li><li>CoreWeave recorded its worst week since November last year.</li><li>Tesla introduced the Roadster sports car, a prototype designed in collaboration with SpaceX.&nbsp;&nbsp;&nbsp;</li></ul><p>U.S. stock indices dropped on Friday, with the Nasdaq 100 recording its worst week in over a year and&nbsp;a half, pulled down by weakness in chip stocks.</p><p>The S&amp;P 500 ended Friday 1.1% lower, the Nasdaq 100 fell 2.5%, and the Dow Jones Industrial Average slipped 0.3%. The Russell 2000, which tracks small-cap stocks, ended 1.7% lower.</p><p>S&amp;P 500 futures slipped 0.2%, while Nasdaq-100 futures dropped 0.7%. Dow Jones Industrial Average futures rose just 22 points.&nbsp;&nbsp;</p><p>The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) dropped 1.2%, and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF</a> (DIA) eased 0.5%. Meanwhile, the Nasdaq-100 tracking&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) fell 2.5% on Friday.&nbsp;&nbsp;</p><p>Meanwhile, the VanEck Semiconductor ETF (<a href="https://stocktwits.com/symbol/SMH">SMH</a>) and the iShares Semiconductor ETF fell between 3% and 4% amid weakness in Micron Tech (MU), Nvidia (NVDA), Broadcom (AVGO), and most other silicon makers. The broader Vanguard Information Technology ETF (VGT) dropped 3%.</p><p>The Roundhill Memory ETF (DRAM) fell about 6% on Friday, with most memory chip stocks in the red.&nbsp;</p><p>Retail sentiment on Stocktwits for QQQ, SPY, and DIA was ‘bearish’ with ‘high’ message volumes.</p><h2 class="st-heading-2"><strong>US Market Drivers</strong></h2><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>-0.3%</td><td>52,002.41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td></tr><tr><td>S&amp;P 500</td><td>-1.1%</td><td>7,659.44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td></tr><tr><td>Nasdaq 100</td><td>-2.5%</td><td>29,187.55&nbsp;&nbsp;</td></tr></tbody></table></figure></div><p>Anxiety rose among market participants over excessive spending and debt tech firms are taking on to finance AI expansion. Neocloud provider CoreWeave saw its stock tumble almost 12%, extending weekly losses to 25% as its overall debt load ballooned past $51 billion.</p><p>Michael Rosen, chief investment officer at Angeles, told CNBC that while mounting debt warrants close monitoring, current levels remain far from systemic danger. “Obviously, increased debt issuance is something to observe and continue to watch and be concerned about if it continues to get to levels of excessiveness. But we’re not remotely close to that right now.”&nbsp;</p><p>Alternatively, Nvidia’s chief Jensen Huang has been publicly advocating for the AI industry by saying the benefits of the technology will soon outweigh the concerns of investors.&nbsp;</p><p>“All of this is going to pass, and the reason for that is very simple,” Huang told Bloomberg during an event in Berlin. “It’s going to be transformative. It’s going to impact in a very positive way every single industry and every single country. There’s no question it will continue, and we’re at the beginning of that.”&nbsp;</p><h2 class="st-heading-2"><strong>Key Trending Stocks</strong></h2><p>Apple Inc. (AAPL) is preparing to fight U.K. antitrust regulators over proposed rule changes designed to break the tech giant’s grip on its iPhone tap-to-pay technology.&nbsp;</p><p>Shares of Michael Saylor-backed Strategy (MSTR) fell on Friday, reversing Thursday’s gains, after MSCI announced it would adopt a new approach to screening companies for its global benchmark indexes that could put the Bitcoin (BTC) treasury firm’s index membership at risk.&nbsp;</p><p>Uber (UBER) shares were in focus after Guggenheim reiterated its ‘Buy’ rating and $125 price target, calling it a “compelling investment opportunity.”&nbsp;</p><p>Tesla’s (TSLA) unveiling of its next-generation Roadster on Thursday turned heads as the car<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Tesla/status/2110913438293647789"> drove</a> off a roller-coaster-like ramp, somersaulting over other Tesla vehicles before using cold-gas thrusters to land, but analysts saw it as a precursor to its merger with SpaceX (SPCX).&nbsp;</p><p>Shares of ExxonMobil (XOM) advanced modestly on Friday after the company said that higher refining margins could add about $4.5 billion to third-quarter results compared with the prior quarter.&nbsp;</p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

Traders work on the floor of the New York Stock Exchange during morning trading on September 14, 2026. (Photo by Michael M. Santiago/Getty Images)

Nasdaq 100 Records Worst Week In 18 Months As Investors Steer Clear Of Chipmakers — AAPL, MSTR, UBER, SOXX In Focus

The Philadelphia Semiconductor Index fell for an eighth straight day, the longest slide since 2008.

Roundhill ETF Trust - Roundhill Memory ETF

VanEck Semiconductor ETF

Philadelphia Semiconductor Index

Direxion Daily Semiconductor Bull 3X Shares

iShares Semiconductor ETF

Exxon Mobil Corp

<ul class="summary-bullets"><li>Iptacopan is sold under the brand name Fabhalta and is approved by the FDA for Paroxysmal Nocturnal Hemoglobinuria, Primary Immunoglobulin A Nephropathy, and C3 Glomerulopathy.</li><li>Novartis has faced multiple clinical setbacks over the past several weeks, including trial failures and development discontinuations.</li><li>According to data from Koyfin, 8 of the 23 analysts rate the stock a ‘buy’ or ‘strong buy,’ while 13 rate it a ‘hold’ and only two rate it ‘sell.’</li></ul><p><br>Shares of Novartis (NVS) closed little changed on Friday after the company decided to discontinue its mid-stage trial of iptacopan in lupus nephritis.</p><p>According to a federal clinical trials registry update, the company has concluded the study over ‘strategic considerations.’ It is unclear if the discontinuation was spurred by efficacy or safety concerns.</p><p>The multi-location study aimed to evaluate the efficacy, safety, and tolerability of iptacopan (LNP023) in addition to standard-of-care treatment. The company decided to conclude the study after completing the first part, as per the database.</p><p>Iptacopan is sold under the brand name Fabhalta and is approved by the FDA for Paroxysmal Nocturnal Hemoglobinuria, Primary Immunoglobulin A Nephropathy, and C3 Glomerulopathy.</p><h2 class="st-heading-2">Latest Pipeline Setback For Novartis</h2><p>Novartis has faced multiple clinical setbacks over the past several weeks. Last month, the company said that its late-stage trial of Pelacarsen, being developed as a treatment to lower elevated lipoprotein(a) or Lp(a) and reduce the risk of major cardiovascular events, missed its primary goal. The company also said that its late-stage trial of del-desiran in myotonic dystrophy type 1 (DM1) missed its primary endpoint.</p><p>Besides the late-stage drug failures, the company also discontinued development of VHB937 in mid-September after a mid-stage study missed primary and secondary goals. &nbsp;Prior to that, in August, Novartis paused multiple autoimmune and neurology trials after three fatal cases of immune effector cell-associated hemophagocytic syndrome (IEC-HS) in patients taking its experimental therapy Rap-cel. &nbsp;</p><p>According to data from Koyfin, 8 of the 23 analysts rate the stock a ‘buy’ or ‘strong buy,’ while 13 rate it a ‘hold’ and only two rate it ‘sell.’</p><h2 class="st-heading-2">How Did NVS Retail Traders React?</h2><p>On Stocktwits, retail sentiment around <a class="mention" data-mention="$NVS" data-symbol-id="NVS" href="https://stocktwits.com/symbol/NVS" target="_blank">NVS stock</a> stayed within the ‘bearish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.</p><p>NVS stock has gained 9% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/asnd-shares-shrug-off-positive-european-opinion-for-fda-approved-achondroplasia-drug/cZxKWRBRBtT">ASND Shares Shrug Off Positive European Opinion For FDA-Approved Achondroplasia Drug</a></p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

In this photo illustration, the Novartis company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Novartis Discontinues Mid-Stage Lupus Trial In Latest Pipeline Setback 

The multi-location study aimed to evaluate the efficacy, safety, and tolerability of iptacopan (LNP023) in addition to standard-of-care treatment in lupus. 

Novartis Discontinues Mid-Stage Lupus Trial In Latest Pipeline Setback

The multi-location study aimed to evaluate the efficacy, safety, and tolerability of iptacopan (LNP023) in addition to standard-of-care treatment in lupus. 


Dimensional ETF Trust - Dimensional International Core Equity Market ETF

Dimensional International Value ETF

Novartis AG

<ul class="summary-bullets"><li>Final European Commission authorization is still pending, with a decision expected in the fourth quarter of 2026 and a potential first launch in Germany in the first quarter of 2027.</li><li>Ascendis has three approved commercial products.</li><li>TransCon CNP, marketed as YUVIWEL in the U.S., received FDA approval in February 2026.</li></ul><p>Ascendis Pharma (ASND) said on Friday that it has received a positive European regulatory opinion for its once-weekly treatment for children with achondroplasia.</p><p>Shares of the company closed down 0.6%, as investors likely viewed the positive opinion as expected, provided it is already approved in the U.S. TransCon CNP, marketed as YUVIWEL in the U.S., received FDA approval in February 2026 to increase linear growth in children two years and older with open growth plates.</p><h2 class="st-heading-2">CHMP Opinion On Ascendis Drug</h2><p>Ascendis said the Committee for Medicinal Products for Human Use adopted a positive opinion on Ascendis’s application seeking approval for the drug in achondroplasia for children two years of age and older whose epiphyses, or the expanded end of a long bone, are not closed.<br><br>The opinion followed review of data from three randomized, double-blind, placebo-controlled trials plus up to three years of open-label extension results, including the pivotal ApproaCH trial. Final European Commission authorization is still pending, with a decision expected in the fourth quarter of 2026 and a potential first launch in Germany in the first quarter of 2027.</p><p>Chief Executive Officer Jan Mikkelsen said the positive opinion reflects the unique profile of TransCon CNP and that the therapy remains a foundational product in the company’s growth disorder portfolio supporting its longer-term objectives.</p><p>Ascendis has three approved commercial products, including TransCon CNP. In the second quarter, or its first quarter of commercial sales, the drug recorded €7.6–8 million in revenue, accounting for a small portion of the company’s overall product revenue of €315 million. YORVIPATH accounts for a lion’s share of the company’s overall sales.</p><h2 class="st-heading-2">How Did ASND Retail Traders React?</h2><p>On Stocktwits, retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/ASND">ASND stock</a>&nbsp;stayed within bearish territory over the past 24 hours, while message volume stayed within normal levels.</p><p>ASND stock has gained 6% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/omeros-shares-slide-after-chmp-upholds-negative-opinion-on-drug-analyst-sees-buying-opportunity-at-16/cZxKQ9ERBtG">Omeros Shares Slide After CHMP Upholds Negative Opinion On Drug; Analyst Sees Buying Opportunity At $16</a></p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

In this photo illustration, the Ascendis Pharma logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

ASND Shares Shrug Off Positive European Opinion For FDA-Approved Achondroplasia Drug

Ascendis said the Committee for Medicinal Products for Human Use adopted a positive opinion on Ascendis’s application seeking approval for the drug in achondroplasia.

Ascendis Pharma

iShares Biotechnology ETF

T Rowe Price Capital Appreciation Equity ETF

<ul class="summary-bullets"><li>Bearish investors accumulated roughly $32 billion in paper profits over seven days as the Philadelphia Semiconductor Index dropped over 12% during an eight-session slump.&nbsp;</li><li>Broad market indexes felt the ripple effect, with the S&amp;P 500 on track for its worst weekly decline since June and the Nasdaq 100 sliding 5%.&nbsp;</li><li>Short sellers betting against AI cloud provider CoreWeave Inc. netted more than $1 billion in mark-to-market profits following distressed debt signals and rising default risks.&nbsp;</li></ul><p>Short sellers have bagged a multi-billion-dollar payday amid a retreat in semiconductor stocks driven by CoreWeave’s debt concerns.&nbsp;</p><p>Short sellers recorded $32 billion in gross paper profits over a seven-day span as the Philadelphia Semiconductor Index plummeted more than 12%, S3 data showed, as quoted by Bloomberg.&nbsp;</p><p>The sector benchmark, widely known as the <a class="mention" data-mention="$SOX" data-symbol-id="SOX" href="https://stocktwits.com/symbol/SOX" target="_blank">SOX</a>, extended its slump to eight consecutive trading days on Friday, putting it on pace to mirror its longest losing streak since 2006.</p><h2 class="st-heading-2"><strong>Market Anxiety Around AI Spending Persist&nbsp;</strong></h2><p>The recent decline reflects growing market anxiety about elevated interest rates, lofty tech valuations, and the massive AI capital expenditures.</p><p>The selloff in chips has spilled over into broader equity benchmarks, setting the S&amp;P 500 up for a 1.7% weekly decline, its steepest since June, while the tech-heavy Nasdaq 100 dropped 5% in the week ending October 16.</p><p>Out of the 30 companies comprising the SOX index, 20 have lost over 10% of their value since the downturn began. Coherent Corp.(COHR) led the losses with a dive of nearly 30%.</p><p>"The run up in chips was very aggressive so invariably there was going to be some consolidation or pull back," Dec Mullarkey of SLC Management told Bloomberg.</p><h2 class="st-heading-2"><strong>CoreWeave Shorts Yield Massive Returns</strong></h2><p>Short sellers targeting CoreWeave Inc. (CRWV), an AI-focused cloud computing firm, logged over $1 billion in gains as the company's equity dropped more than 20% over the week.</p><p>CoreWeave's debt instruments slipped into distressed territory, with credit-default swaps indicating a greater than 50% likelihood of default over the next five years.S3 data noted that a portion of the short interest in CoreWeave stems from convertible bond arbitrage strategies rather than purely directional bearish bets.</p><p>"CoreWeave specifically is going to need a new story," Joe Tigay, portfolio manager of the Rational Equity Armor Fund told Bloomberg. "It's going to need time to digest this new reality."</p><p>The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) dropped 1.2%, and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF</a> (DIA) eased 0.5%. Meanwhile, the Nasdaq-100 tracking&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) fell 2.5% on Friday.&nbsp;&nbsp;</p><p>&nbsp;<i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Trading digital board showing the data on global stock market crash. | Image source: Getty Images

Short Sellers Have Earned $32B Over The Past Week Amid Chipmaker Selloff: Report

Short sellers have bagged a multi-billion-dollar payday amid a retreat in semiconductor stocks driven by CoreWeave’s debt concerns.

Short Sellers Have Earned $32B Over The Past Week Amid Chipmaker Selloff

The recent drop in semiconductor stocks led by CoreWeave has generated an estimated $32 billion in paper gains for bearish investors in just seven days.

Latest Market News

Stocktwits Sentiment Index